Results 171 to 180 of about 213,470 (338)
Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine
ESC Heart Failure, Volume 12, Issue 2, Page 923-926, April 2025.
Riccardo M. Inciardi +3 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Aims Angiotensin receptor‐neprilysin inhibitor (ARNI) therapy has demonstrated improved outcomes in heart failure with reduced ejection fraction (HFrEF). However, its benefits in patients with concomitant kidney failure undergoing replacement therapy remain uncertain. Methods and results Using the National Health Insurance Service database, we
Mi‐Hyang Jung +8 more
wiley +1 more source
STUDIES OF GLYCOGEN METABOLISM IN LIVER GLYCOGEN DISEASE (VON GIERKE'S DISEASE): SIX CASES WITH SIMILAR METABOLIC ABNORMALITIES AND RESPONSES TO GLUCAGON* [PDF]
, 1961 Joseph E. Sokal +4 more
openalex +1 more source
ESC Heart Failure, EarlyView.Abstract Clinical endpoint classification (CEC)—that is, evaluation of clinical events using pre‐defined criteria—is commonly conducted in clinical trial operations to ensure systematic and consistent assessment of endpoints needed to assess the intervention's safety and efficacy.
Veraprapas Kittipibul +13 more
wiley +1 more source
Mechanism for the Stimulation in vivo of Hepatic Gluconeogenesis by Glucagon [PDF]
, 1966 John Williamson
openalex +1 more source
European Journal of Heart Failure, EarlyView.Clinical evidence in transcatheter edge‐to‐edge valve repair. EF, ejection fraction; eGFR, estimated glomerular filtration rate; EROA, effective regurgitant orifice area; GDMT, guideline‐directed medical therapy; HF, heart failure; HHF, hospitalization for heart failure; LVEDV, left ventricular end‐diastolic volume; MR, mitral regurgitation; MVARC ...
Gianluigi Savarese +13 more
wiley +1 more source
Glucagon, insulin and ‘anaphylactoid’ inflammation
, 1959 L Adamkiewicz, V. W. Adamkiewicz
openalex +2 more sources
Comparison of Glucagon and Epinephrine Effects in the Dog [PDF]
, 1966 Ediz Z. Ezdinli, Joseph E. Sokal
openalex +1 more source
Cardioprotective effects of semaglutide on isolated human ventricular myocardium
European Journal of Heart Failure, EarlyView.Semaglutide reduces late sodium current (INa) and diastolic calcium (Ca) sparks in human cardiomyocytes from aortic stenosis (AS) and end‐stage heart failure with reduced ejection fraction (HFrEF) patients, thereby increasing Ca transients. Improved Ca storage may underly the enhanced contractility of human cardiomyocytes upon semaglutide.
Thomas Krammer +16 more
wiley +1 more source
Diabetes, Metabolic Syndrome and ObesityLina Chang,* Xiaohui Ma,* Menghua Yuan,* Li Ding, Yian Gu, Lili Liu, Yan Li, Hua Shu, Ming Liu, Qing He Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China*These ...
Chang L +9 more
doaj